Depei, C., Zhiying, J. & Yumin, S. Research on treatment of female idiopathic precocious puberty with combined traditional Chinese medicine and megestrol acetate., CJIM 4, 267–271 (1998). https://doi.org/10.1007/BF02935474
Cai Depei, Ji Zhiying, Shi Yumin. Research on treatment of female idiopathic precocious puberty with combined traditional Chinese medicine and megestrol acetate. [J]. Chinese Journal of Integrative Medicine 4(4):267-271(1998)
Depei, C., Zhiying, J. & Yumin, S. Research on treatment of female idiopathic precocious puberty with combined traditional Chinese medicine and megestrol acetate., CJIM 4, 267–271 (1998). https://doi.org/10.1007/BF02935474DOI:
Cai Depei, Ji Zhiying, Shi Yumin. Research on treatment of female idiopathic precocious puberty with combined traditional Chinese medicine and megestrol acetate. [J]. Chinese Journal of Integrative Medicine 4(4):267-271(1998) DOI: 10.1007/BF02935474.
Research on treatment of female idiopathic precocious puberty with combined traditional Chinese medicine and megestrol acetate
摘要
Objective: To find effective therapeutic approach for treating true idiopathic precocious puberty suitable to our national condition and different from gonadotrophin releasing hormone analogue.Methods: One hundred and six girls with idiopathic precocious puberty were divided into 3 groups. The 51 girls in the TCM-WM group were treated with Chinese herbal medicine combined with megestrol acetate (MA)
35 girls in the MA group treated with megestrol acetate alone
and 20 girls were taken as control group and given no treatment at all. Luteinizing hormone releasing hormone (LHRH) stimulating test were performed before and after treatment
and the size of the uterus and ovary
linear growth rate
X-ray bone age measurement and final height prediction were also observed simultaneously.Results: After treated with TCM-WM for 2.7 years in average
the luteinizing hormone (LH) peak value of LHRH stimulating test was reduced from 48.5 ± 5.2 IU/L to 12. 2 ± 1.3 IU/L
size of uterus and ovary decreased
secondary sexual characteristics regressed
the bone age difference/chronological age difference value (ΔBA/ΔCA) reduced from 1.35 ± 0.09 to 0.65 ± 0.05 and predictive final height increased from 153.3 ± 0.5 cm to 158.5 ± 0.6 cm.Conclusion: TCM-WM therapy could not only modulate the function of hypothalamic-pituitary-ovarian axis and the development of internal genitalia
but also could decelerate skeletal growth
delay skeletal maturation
and thereby prevent premature epiphyseal fusion and increase the final height of patients.
Abstract
Objective: To find effective therapeutic approach for treating true idiopathic precocious puberty suitable to our national condition and different from gonadotrophin releasing hormone analogue.Methods: One hundred and six girls with idiopathic precocious puberty were divided into 3 groups. The 51 girls in the TCM-WM group were treated with Chinese herbal medicine combined with megestrol acetate (MA)
35 girls in the MA group treated with megestrol acetate alone
and 20 girls were taken as control group and given no treatment at all. Luteinizing hormone releasing hormone (LHRH) stimulating test were performed before and after treatment
and the size of the uterus and ovary
linear growth rate
X-ray bone age measurement and final height prediction were also observed simultaneously.Results: After treated with TCM-WM for 2.7 years in average
the luteinizing hormone (LH) peak value of LHRH stimulating test was reduced from 48.5 ± 5.2 IU/L to 12. 2 ± 1.3 IU/L
size of uterus and ovary decreased
secondary sexual characteristics regressed
the bone age difference/chronological age difference value (ΔBA/ΔCA) reduced from 1.35 ± 0.09 to 0.65 ± 0.05 and predictive final height increased from 153.3 ± 0.5 cm to 158.5 ± 0.6 cm.Conclusion: TCM-WM therapy could not only modulate the function of hypothalamic-pituitary-ovarian axis and the development of internal genitalia
but also could decelerate skeletal growth
delay skeletal maturation
and thereby prevent premature epiphyseal fusion and increase the final height of patients.
关键词
precocious pubertyTraditional Chinese MedicineMegestrolskeletal developmenthypothalamic-pituitary-ovarian axis
Keywords
precocious pubertyTraditional Chinese MedicineMegestrolskeletal developmenthypothalamic-pituitary-ovarian axis
references
Wheeler MD, Styne DM. The treatment of precocious puberty. Endocr Metab Clin North Am 1991; 20(1):183–190.
Job J-C, Pierson M. Pediatric Endocrinology, ed 1. New York: John Wiley & Sons. 1981:378, 403–404.
Comite F, Cassorla F, Barnes KM, et al. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. JAMA 1986; 255: 2613.
Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards. J Pediat 1952; 40(4): 434.
Lee PA. Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child 1981; 135: 443.
Pathogenetic regulation of female precocious puberty and the mechanism of therapy with traditional Chinese medicine
Changes of cerebral β-endorphin in rats treated with combination therapy of melatonin and electroacupuncture
Syndrome pattern and its application in parallel randomized controlled trials
Integration of Chinese medicine and Western medicine in clinical practice (Patient Care): Past, present, and a proposed model for the future
The Western model of integrative oncology — the contribution of Chinese medicine
Related Author
No data
Related Institution
Pediatrics Hospital of Shanghai Medical University
Department of Neurobiology, Shanghai Medical University
Shanghai PASIC Bio-engineering Institute
Department of Neurobiology, Institute of Acupuncture Research, State Key Laboratory of Medical Neurobiology, Medical Center of Fudan University (the former Shanghai Medical University)
Division of Clinical Medicine, School of Korean Medicine, Pusan National University, Yangsan, Republic of Korea